Boots owner rejects accusations it overcharged NHS for cancer mouthwash

Written by Joseph Nordqvist

Published: 05:18, May 27, 2018

Walgreens Boots Alliance has rejected accusations that it has been overcharging the NHS for a mouthwash used by cancer patients.

The announcement by the company follows an investigation by the Times newspaper which found that Boots charged the NHS £3,220 for a medicinal mouthwash that can cost as low £93.

The Times claims that Boots used a legal loophole which lets suppliers set their own prices for these drugs. The mouthwash was ordered from a supplier owned by Boot’s parent company.

The paper said Boots charged £3,219 to supply three 200ml bottles from 2013-2017, then charged £3,220 for the same amount, £1,843 for an 800ml treatment, £1,989.12 for 800ml and £6,374.25 for 2,600ml.

Meanwhile, a pharmacy in West Sussex charged £31.14 for one 200ml bottle in 2016.

Walgreens Boots Alliance is the US-based parent company of the UK pharmacy Boots.

A Walgreens Boots Alliance spokesman said: “We firmly reject accusations of overcharging the NHS.

“Our senior company leaders have already recently met with officials from the Department of Health to discuss the specials products.”

Health Minister Steve Brine has called for the Competition and Markets Authority to carry out an investigation into the matter.

Brine said the public would take “an extremely dim view of any company found to be exploiting our NHS and patients”.

“We have asked the Competition and Markets Authority to consider investigating as a priority,” he said.

Adding:

“We have changed the law to enable us to place pharmacies and manufacturers under much stronger scrutiny.

“Where there is evidence of collusion between pharmacies and suppliers swift action will be taken to claw back funds and penalise offenders.”

 

Joseph Nordqvist Avatar

Other News

A fee to place a bid can lift a seller’s profit, but the effect may fade

Nov 10, 2026

Experiences can make loyalty rewards more engaging, retail research finds

Nov 10, 2026

Most emerging-market firms in an IFC survey use AI, but few have embedded it across core operations

Nov 10, 2026

Startups given examples of AI workflows found more uses for the technology

Nov 9, 2026

Showing product costs can change how shoppers judge a brand’s motives

Nov 9, 2026

Hiding most Facebook ads increased users’ time on the platform in a study

Nov 9, 2026

Online sales remain a small share of revenue for many Balkan businesses

Nov 9, 2026

Toast faces FTC lawsuit over restaurant software fees and cancellations

Nov 9, 2026

Fashion ads featuring models with disabilities performed better in a set of tests

Nov 8, 2026

Ad comment moderation showed mixed results in Harvard research

Nov 8, 2026

Board connections are linked to marketing’s influence inside companies

Nov 8, 2026

Customer confidence can fall before it rises with experience, study finds

Nov 8, 2026

Drug buyers often cut promotion while raising prices, research finds

Nov 8, 2026

Confirmation prompts can change subscription choices, but add checkout friction

Nov 8, 2026

Marketplace advertising adds a second cost to reaching online shoppers

Nov 7, 2026

Delivery and payment choices can stop online sales at checkout, DHL survey finds

Nov 7, 2026

AI-translated marketing videos drew mixed reactions in two language tests

Nov 7, 2026

Referrals remain a major source of leads for small businesses, survey finds

Nov 7, 2026

Company size can influence who posts online reviews, research finds

Nov 7, 2026

New-customer ads beat retargeting in a mattress seller’s field experiment

Nov 7, 2026